263 related articles for article (PubMed ID: 16170379)
41. Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib--a single institution historical experience.
Yin XF; Ma QL; Mu QT; Shao L; Wang SS; Meng HT; Xu WL; Wang YG; Chen ZM; Chen FF; Jin J
Leuk Res; 2014 Oct; 38(10):1191-8. PubMed ID: 25115808
[TBL] [Abstract][Full Text] [Related]
42. Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.
Chung HJ; Chi HS; Cho YU; Park CJ; Seo EJ; Kim KH; Lee JH
Ann Clin Lab Sci; 2008; 38(3):283-6. PubMed ID: 18715859
[TBL] [Abstract][Full Text] [Related]
43. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
44. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations.
Wei Y; Hardling M; Olsson B; Hezaveh R; Ricksten A; Stockelberg D; Wadenvik H
Ann Hematol; 2006 Dec; 85(12):841-7. PubMed ID: 17006667
[TBL] [Abstract][Full Text] [Related]
45. Pathobiology of lymphoid and myeloid blast crisis and management issues.
Ilaria RL
Hematology Am Soc Hematol Educ Program; 2005; ():188-94. PubMed ID: 16304379
[TBL] [Abstract][Full Text] [Related]
46. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34
Maupetit-Mehouas S; Court F; Bourgne C; Guerci-Bresler A; Cony-Makhoul P; Johnson H; Etienne G; Rousselot P; Guyotat D; Janel A; Hermet E; Saugues S; Berger J; Arnaud P; Berger MG
Mol Oncol; 2018 Jun; 12(6):814-829. PubMed ID: 29575763
[TBL] [Abstract][Full Text] [Related]
48. Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
Li Z; Luo J
Biochem Biophys Res Commun; 2018 Jun; 501(1):64-72. PubMed ID: 29704505
[TBL] [Abstract][Full Text] [Related]
49. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis.
Takai D; Yagi Y; Habib N; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2000 Jul; 30(7):306-9. PubMed ID: 11007163
[TBL] [Abstract][Full Text] [Related]
50. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
Mori N; Morosetti R; Spira S; Lee S; Ben-Yehuda D; Schiller G; Landolfi R; Mizoguchi H; Koeffler HP
Blood; 1998 Nov; 92(9):3405-9. PubMed ID: 9787180
[TBL] [Abstract][Full Text] [Related]
51. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
[TBL] [Abstract][Full Text] [Related]
53. Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.
Yeh CH; Tseng R; Zhang Z; Cortes J; O'Brien S; Giles F; Hannah A; Estrov Z; Keating M; Kantarjian H; Albitar M
Leuk Res; 2009 Feb; 33(2):212-7. PubMed ID: 18715642
[TBL] [Abstract][Full Text] [Related]
54. Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.
Heller G; Topakian T; Altenberger C; Cerny-Reiterer S; Herndlhofer S; Ziegler B; Datlinger P; Byrgazov K; Bock C; Mannhalter C; Hörmann G; Sperr WR; Lion T; Zielinski CC; Valent P; Zöchbauer-Müller S
Leukemia; 2016 Sep; 30(9):1861-8. PubMed ID: 27211271
[TBL] [Abstract][Full Text] [Related]
55. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia.
Ochi Y; Yoshida K; Huang YJ; Kuo MC; Nannya Y; Sasaki K; Mitani K; Hosoya N; Hiramoto N; Ishikawa T; Branford S; Shanmuganathan N; Ohyashiki K; Takahashi N; Takaku T; Tsuchiya S; Kanemura N; Nakamura N; Ueda Y; Yoshihara S; Bera R; Shiozawa Y; Zhao L; Takeda J; Watatani Y; Okuda R; Makishima H; Shiraishi Y; Chiba K; Tanaka H; Sanada M; Takaori-Kondo A; Miyano S; Ogawa S; Shih LY
Nat Commun; 2021 May; 12(1):2833. PubMed ID: 33990592
[TBL] [Abstract][Full Text] [Related]
56. Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.
Nguyen TT; Mohrbacher AF; Tsai YC; Groffen J; Heisterkamp N; Nichols PW; Yu MC; Lübbert M; Jones PA
Blood; 2000 May; 95(9):2990-2. PubMed ID: 10779450
[TBL] [Abstract][Full Text] [Related]
57. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
Yang MY; Liu TC; Chang JG; Lin PM; Lin SF
Blood; 2003 Apr; 101(8):3205-11. PubMed ID: 12506033
[TBL] [Abstract][Full Text] [Related]
58. The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia.
Chen Q; Lin J; Qian J; Deng ZQ; Qian W; Yang J; Li Y; Chen XX; Ma YJ; Ma JC; Liu Q
Genet Test Mol Biomarkers; 2013 Jun; 17(6):508-11. PubMed ID: 23495895
[TBL] [Abstract][Full Text] [Related]
59. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
[TBL] [Abstract][Full Text] [Related]
60. Sudden blast crisis in chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Hiwase DK; Hughes TP
Leuk Lymphoma; 2012 Jul; 53(7):1251-2. PubMed ID: 22475357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
